- €839.74m
- €829.72m
- €131.69m
Brief: PharmaNutra Q1 Net Profit Up To EUR 3.5 Mln
Brief: Pharmanutra FY Net Profit Down To EUR 13.8 Mln
Brief: Pharmanutra Says UE Authorises CFA As Novel Food
Brief: Pharmanutra 2021 Global Sales Up At 9.7 Mln Units On Italian, International Markets
Brief: Pharmanutra Obtains Licence For CFA Use In USA
Brief: Pharmanutra Signs Distribution Deal In Taiwan
Italy - Factors to watch on Dec. 20
Brief: PharmaNutra Signs Distribution Deal For Sideral® Products In Argentina
Brief: Pharmanutra 9-Month Net Profit Down At EUR 10.9 Mln
Brief: PharmaNutra Unit Obtains Patent For New Sucrosomial Berberine Ingredient
Brief: PharmaNutra Signs Three Distribution Contracts For SiderAl, Cetilar Products
Brief: PharmaNutra 9-Month Total Volume Of Units Sold Up 18.2% At 6.6 Mln
Brief: Pharmanutra H1 Net Profit Down At EUR 7.0 Mln
Brief: PharmaNutra Says EFSA In Favour Of Authorising Lipocet As Novel Food
Brief: Pharmanutra Signs Contract With SACAIM
Brief: PharmaNutra Signs Deal With Fresenius Kabi For Distribution Of SiderAl In Germany
Brief: PharmaNutra Q1 Net Profit Down At EUR 2.5 Mln
Brief: Pharmanutra FY Net Profit Up At EUR 14.1 Mln
Italy - Factors to watch on Dec. 15